COMP <GO>
SPRO vs CPIX // GROSS PROFIT MARGIN
Spero Therapeutics Inc. (NASDAQ) VS. Cumberland Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: SPRO 5
— CPIX 4
■ METRIC PARITY
LAST: $1.06 (-4.50%) • MKT CAP: $64.6M
gross-margins
—
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
gross-margins
85.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SPRO VS. CPIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SPRO | CPIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 85.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.60% | -16.40% | +43.00 | SPRO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -19.53% | 7.42% | -26.95 | CPIX | /fcf-yield <GO> |
| Operating Margin | 50.20% | -6.30% | +56.50 | SPRO | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -6.40% | +74.40 | SPRO | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 17.60% | +162.40 | SPRO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.72 | -0.52 | CPIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.2 | 35.3 | +5.94 | SPRO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.6M | $65.2M | -$535.9K | CPIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SPRO REV | CPIX REV | SPRO GROSS % | CPIX GROSS % | SPRO FCF | CPIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.6M | $44.5M | — | 85.0% | -$12.6M | $4.8M |
| FY 2024 | $371.0K | $37.9M | — | 82.6% | -$23.4M | -$678.6K |
| FY 2023 | $933.0K | $39.6M | — | — | -$33.0M | $6.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SPRO // BETA —
CPIX // BETA —